PGR and neoplasm: We observed positive progesterone receptor staining in the tumor samples of 13 patients of the N1 group, of which 7 samples were from male patients and 6 were from female patients, with no statistically significant between-gender difference in PR staining (p = 1.000) (Fig. 1).